Selective Crossover in Randomized Trials of Adjuvant Trastuzumab for Breast Cancer: Coping with Success

被引：0
|
作者：
Regan, M. M.
Dafni, U.
Karlis, D.
Goldhirsch, A.
Untch, M.
Smith, I.
Gianni, L.
Jackisch, C.
de Azambuja, E.
Heinzmann, D.
Cameron, D.
Bell, R.
Dowsett, M.
Baselga, J.
Leyland-Jones, B.
Piccart-Gebhart, M. J.
Gelber, R. D.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Athens, Athens, Greece
[3] Frontier Sci Fdn Hellas, Athens, Greece
[4] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium
[5] Helios Klinikum Berlun Buch, Berlin, Germany
[6] Royal Marsden Hosp, London SW3 6JJ, England
[7] Inst Canc Res, London SW3 6JB, England
[8] San Raffaele Inst, Milan, Italy
[9] Western Gen Hosp, Edinburgh, Midlothian, Scotland
[10] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland
[11] Royal Marsden NHS Trust, London, England
[12] European Inst Oncol, Milan, Italy
[13] Athens Univ Econ, Athens, Greece
[14] Massachusetts Gen Hosp, Boston, MA 02114 USA
[15] F Hoffmann La Roche, Basel, Switzerland
[16] Sanford Res, Sioux Falls, SD USA
[17] Geelong Hosp, Andrew Love Canc Ctr, Geelong, Vic, Australia
[18] Klinikum Offenbach, Offenbach, Germany
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-P5-18-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-18-02
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Trastuzumab in the Adjuvant Treatment of HER2-Positive Early Breast Cancer Patients: A Meta-Analysis of Published Randomized Controlled Trials
    Yin, Wenjin
    Jiang, Yiwei
    Shen, Zhenzhou
    Shao, Zhimin
    Lu, Jinsong
    PLOS ONE, 2011, 6 (06):
  • [32] Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer:: the dark side of the moon?: A meta-analysis of the randomized trials
    Bria, Emilio
    Cuppone, Federica
    Fornier, Monica
    Nistico, Cecilia
    Carlini, Paolo
    Milella, Michele
    Sperduti, Isabella
    Terzoli, Edmondo
    Cognetti, Francesco
    Giannarelli, Diana
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (02) : 231 - 239
  • [33] Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials
    Emilio Bria
    Federica Cuppone
    Monica Fornier
    Cecilia Nisticò
    Paolo Carlini
    Michele Milella
    Isabella Sperduti
    Edmondo Terzoli
    Francesco Cognetti
    Diana Giannarelli
    Breast Cancer Research and Treatment, 2008, 109 : 231 - 239
  • [34] Cost considerations in determining the affordability of adjuvant trastuzumab in breast cancer
    Abratt, R. P.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2016, 106 (10): : 46 - 47
  • [35] Sudden death during adjuvant trastuzumab therapy of breast cancer
    Oliveira, M.
    Nave, M.
    Gil, N.
    Passos-Coelho, J. L.
    ANNALS OF ONCOLOGY, 2010, 21 (04)
  • [36] Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK
    Earl, H. M.
    Hiller, L.
    Dunn, J.
    Macpherson, I.
    Rea, D.
    Hughes-Davies, L.
    McAdam, K.
    Hall, P.
    Mansi, J.
    Wheatley, D.
    Abraham, J. E.
    Caldas, C.
    Gasson, S.
    O'Riordan, E.
    Wilcox, M.
    Miles, D.
    Cameron, D. A.
    Wardley, A.
    CLINICAL ONCOLOGY, 2021, 33 (01) : 15 - 19
  • [37] Adjuvant Trastuzumab in HER2-Positive Breast Cancer
    Slamon, Dennis
    Eiermann, Wolfgang
    Robert, Nicholas
    Pienkowski, Tadeusz
    Martin, Miguel
    Press, Michael
    Mackey, John
    Glaspy, John
    Chan, Arlene
    Pawlicki, Marek
    Tamas Pinter
    Valero, Vicente
    Liu, Mei-Ching
    Sauter, Guido
    von Minckwitz, Gunter
    Visco, Frances
    Bee, Valerie
    Buyse, Marc
    Bendahmane, Belguendouz
    Tabah-Fisch, Isabelle
    Lindsay, Mary-Ann
    Riva, Alessandro
    Crown, John
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (14): : 1273 - 1283
  • [38] Adjuvant trastuzumab for HER2-positive breast cancer
    Spicer, J
    Harries, M
    Ellis, P
    LANCET, 2005, 366 (9486): : 634 - 634
  • [39] Cardiotoxicity risks of adjuvant trastuzumab in Asian breast cancer patients
    Shih, V.
    Chan, A.
    Chiang, J.
    Teo, C.
    Chen, J.
    Wong, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [40] Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer
    Munoz, A.
    Carrera, S.
    Ferreiro, J.
    de Lobera, A. Ruiz
    Mane, J. M.
    Lopez-Vivanco, G.
    ANNALS OF ONCOLOGY, 2007, 18 (12) : 2045 - 2046
12345